PEOPLE - Inion makes appointment:
This article was originally published in Clinica
Tampere, Finland-based Inion has appointed Chris Lee as chief commercial officer, effective from January 2007. Mr Lee joins the company, which specialises in developing biodegradeable medical implants, from the J&J subsidiary Ethicon Products, where he is currently president for Europe, Middle East and Africa. The company also announced that the firm's CEO, Auvo Kaikkonen, is to take on the role of COO.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.